Search Orphan Drug Designations and Approvals
-
| Generic Name: | live attenuated bioengineered Listeria monocytogenes immunotherapy |
|---|---|
| Date Designated: | 11/04/2013 |
| Orphan Designation: | Treatment of human papilloma virus-associated head and neck cancer |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Ayala Pharmaceuticals, Inc. 9 Deer Park Drive, Suite K-1 Monmouth Junction, New Jersey 08852 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







